Journal articleClin Cancer Res2026
Efficacy of Actinium-225-Labeled Fully Human Anti-MUC-16 Radioimmunoconjugate against MUC-16-Positive Ovarian and Pancreatic Ductal Adenocarcinoma Xenograft Models.
- Journal
- Clin Cancer Res
- Published
- 1 November 2026
- Citations
- 0
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try